A

Atrium Therapeutics

Develops RNA drugs for rare genetic heart diseases

Associate Director - Pharmacokinetics & Pharmacodynamics

Quantitative Biology & BiostatisticsConfirmed live in the last 24 hours
Full-timeSan Diego, CA, USARemote

About the Job

Requirements

  • A PhD in Pharmacokinetics, Pharmaceutical Sciences, Pharmacology, Analytical Chemistry, Biochemistry, or a related field is required.
  • At least 8 years of biopharma or biotech experience in nonclinical and clinical pharmacokinetics and pharmacodynamics and regulated bioanalysis, including advancing programs from research into development, authoring or supporting Investigational New Drug submissions, and participating in regulatory interactions.
  • Hands-on experience designing and interpreting nonclinical and clinical pharmacokinetics studies, including noncompartmental analysis, and a strong understanding of pharmacokinetics and pharmacodynamics principles.
  • Working knowledge of regulated bioanalysis, including ICH M10 and good laboratory and clinical practice, and experience overseeing pharmacokinetics and anti-drug antibody assay development and sample analysis at contract research organizations.
  • Prior experience managing and developing scientific staff at multiple levels, including PhD and non-PhD scientists.
  • Ability to lead cross-functional initiatives and communicate complex data clearly to project teams and leadership.
  • Ability to work in a small-company environment, take initiative, operate amid ambiguity, and solve problems hands-on.

Responsibilities

  • Support pharmacokinetics and pharmacodynamics across programs from research through late-phase clinical development, including design, oversight, and interpretation of nonclinical and clinical pharmacokinetics, toxicokinetics, and tissue-distribution studies.
  • Apply pharmacokinetics and pharmacodynamics principles to relate exposure to target engagement and pharmacodynamic biomarkers, inform dose selection, support first-in-human dose rationale, and assess the impact of immunogenicity on pharmacokinetics where relevant.
  • Set phase-appropriate bioanalytical strategy and oversee development of good laboratory practice-compliant pharmacokinetics and anti-drug antibody assays in plasma and tissue matrices.
  • Oversee contract research organization management, including requests for proposals, statements of work, budgets, timelines, and sample logistics.
  • Represent pharmacokinetics and pharmacodynamics on project and study teams; communicate strategy and data interpretation; and support regulatory documents, including Investigational New Drug and Clinical Trial Application submissions, briefing books, protocols, and clinical study reports.
  • Manage, mentor, and develop a team of PhD and non-PhD scientists; set priorities, support career development, and build a collaborative, high-performing culture.

Desired Qualifications

  • Experience with oligonucleotides, including small interfering RNA or antisense oligonucleotides, and/or large-molecule therapeutics.

About the Company

Atrium Therapeutics

Develops RNA drugs for rare genetic heart diseases

Atrium Therapeutics develops RNA-based therapies for rare, life-threatening genetic heart diseases. It aims to deliver RNA drugs specifically to heart muscles, using a proprietary platform that pairs tissue-targeting monoclonal antibodies with oligonucleotides for precise genetic modulation. Unlike broader biopharma players, Atrium focuses on cardiomyopathies with no approved treatments and operates at the preclinical stage with two main candidates, ATR 1072 (PRKAG2 syndrome) and ATR 1086 (PLN cardiomyopathy), plus undisclosed targets. The company’s goal is to treat the underlying genetic causes of these diseases and bring therapies to patients who currently have no options.

Company size
51-200
Company stage
IPO
Headquarters
San Diego, CA
Founded
2025

Recently Posted Jobs

Explore more opportunities at Atrium Therapeutics

See more jobs